placeSouth Africa
Contact us
Minimally Invasive Therapies / Clinical Solutions / Uterine Tissue Removal

YOU ARE ENTERING HCP CONTENT ONLY

Please note you are entering now content intended only for Healthcare Professionals.

Are you a HCP?

Setting the standard in hysteroscopic tissue removal

More than 10 years of clinical experience

Featuring fast1, efficient resection, advanced fluid management and pathology optimized tissue removal devices, the TruClear™ system offers a complete technology platform for the removal of a range of intrauterine abnormalities.

 

ONE HIGH PERFORMANCE SYSTEM

“With the TruClear system, I can address a wide spectrum of abnormalities with one high-performing system.”
  Dr. Charles E. Miller, Advocate Lutheran General Hospital, Park Ridge, IL

A MORE COMPLETE AND EFFICIENT RESECTION

With 2% of the lesions remaining in situ after a TruClear™ procedure compared to 87% after a blind D&C, the TruClear™ system offers a clear advantage over traditional methods.1,2

Compared to electrical resection, a TruClear™ procedure is also faster, safer and less painful.1,3

MULTIPLE PROCEDURES

As the only pathology-optimized, hysteroscopic tissue removal system, the TruClear™ system enables more efficient1 procedures and enhanced performance for a full spectrum of conditions, including:

TruClear™ Polypectomy

  • May improve the efficiency of polyp removal by reducing polypectomy procedure time by half3 that of electrical resection
  • Is more likely to completely remove polyps compared to electrical resection1
  • Offers unimpeded access to all pathology within the cavity and resects polyps down to the base
  • Minimizes patient discomfort because of small scope diameters
  • Allows the treatment to be conducted in outpatient clinic with no or only local anesthesia

TruClear™ Myomectomy

  • Brings speed, efficiency and precision to the removal of intrauterine myomas
  • Helps ensure patient safety through advanced fluid management
  • Reduces the risk of traumatic injury to the uterus4
  • In trials assessing the efficacy of the TruClear™ system, on average 97% of endometrial polyps and 90% of uterine fibroids were successfully removed on first attempt1,3,5-7
  • Hysteroscopic removal of these pathologies has been shown to provide substantial to significant improvement in patient quality of life8-9

TruClear™ Retained Products of Conception Evacuation

  • Minimizes endometrial damage by evacuating RPOC under direct visualization
  • Captures tissue for histological confirmation
  • Potentially reduces the need for additional procedures as the system has demonstrated complete removal in over 94% of patients6

Touch Surgery™ Operative Hysteroscopy for RPOC in the OR

Gain insight into how to remove retained products of conception under direct visualization in this Interactive, app-based simulation with virtual procedure footage.

Learn More

Hysteroscopy Product Portfolio

TruClear™ Hysteroscopic Tissue Removal System
 

TruClear™ Elite & 5C Hysteroscopes

TruClear™ Tissue Shavers

HysteroLux™ Fluid Management System

Outpatient Hysteroscopy

Truclear Facilitates Outpatient operative Hysteroscopy

Check out how

Get a Clear Advantage in your Procedures
 
  • 1. Smith, PP, MBChB; Middleton, LJ, MSc; Connor, M, MD and Clark, TJ, MD (2014). Hysteroscopic Morcellation Compared With Electrical Resection of Endometrial Polyps.(2014). Obstetrics & Gynecology, 123(4), 745-751.
  • 2. Epstein E, Ramirez A, Skoog L, Valentin L. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand. 2001;80(12):1131–1136.
  • 3. Emanuel, M.H., and Wamsteker, K. (2005). “The Intra Uterine Morcellator: A New Hysteroscopic Operating Technique to Remove Intrauterine Polyps and Myomas.” TheJournal of Minimally Invasive Gynecology 12(1), 62-66.
  • 4. NICE. Hysteroscopic morcellation of uterine leiomyomas (fibroids). 2015:1-9.
  • 5. van Dongen H, Emanuel MH, Wolterbeek R, Trimbos JB, Jansen FW. Hysteroscopic morcellator for removal of intrauterine polyps and myomas: a randomized controlled pilot study among residents in training. J Minim Invasive Gynecol. 2008;15(4):466-471.
  • 6. Hamerlynck, TWO, MD; Blikkendaal, MD, MD; Schoot, BC, MD, PhD; Hanstede, MMF, MDand Jansen, FW, MD, PhD. (2013). “An Alternative Approach for Removal of PlacentalRemnants: Hysteroscopic Morcellation.” JMIG December 2013 20(6), 796-802.
  • 7. Pampalona JR, Bastos MD, Moreno GM, et al. A comparison of hysteroscopic mechanical tissue removal with bipolar electrical resection for the management of endometrial polyps in an ambulatory care setting: preliminary results. J Minim Invasive Gynecol. 2015;22(3):439-445.
  • 8. Cooper N a. M, Clark TJ, Middleton L, et al. Outpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study. Bmj. 2015;350(mar23 6):h1398-h1398.
  • 9. Clark TJ, Middleton LJ, Cooper NA, et al. A randomised controlled trial of outpatient versus inpatient polyp treatment(OPT) for abnormal uterine bleeding. Health Technol Assess (Rockv). 2015;19(61):1-194.
  • 10. Raw data from Hysteroscopic Morcellation Compared with Electrical Resection of Endometrial Polyps. Smith, P et al, S&N Report# 15002510
CORPORATE RESOURCES
Minimally Invasive Therapies
Medtronic Africa

Waterfall Distribution Campus

Corner K101 & Bridal Veil Road

Waterfall, Midrand, Gauteng

1685

South Africa

©2025 Medtronic